QR Code

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries. To further enhance the protective immune responses in populations that have completed vaccination...

Description complète

Enregistré dans:
Auteurs principaux: Jialu Zhang, Qian He, Chaoqiang An, Qunying Mao, Fan Gao, Lianlian Bian, Xing Wu, Qian Wang, Pei Liu, Lifang Song, Yaqian Huo, Siyuan Liu, Xujia Yan, Jinghuan Yang, Bopei Cui, Changgui Li, Junzhi Wang, Zhenglun Liang, Miao Xu
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis Group 2021-01-01
Collection:Emerging Microbes and Infections
Sujets:
Heterologous
prime-boost
inactivated
SARS-CoV-2
vaccine
neutralizing antibody
Accès en ligne:https://www.tandfonline.com/doi/10.1080/22221751.2021.1957401
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires